<DOC>
	<DOC>NCT01200407</DOC>
	<brief_summary>The purpose of this study is to determine the safety, tolerability and efficacy of Amlodipine and Olmesartan medoxomil among Hypertensive Filipino patients.</brief_summary>
	<brief_title>Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Amlodipine Besylate, Olmesartan Medoxomil Drug Combination</mesh_term>
	<criteria>Filipino hypertensive subjects ages 1865 years old whether naive or currently taking any other antihypertensive or those on monotherapy using CCBs or ARBs whom they want to shift on a fixed dose combination drug Patients with contraindications to any of the component of the fixed drug (amlodipine or olmesartan medoxomil) or with malignant or secondary hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>fixed drug combination</keyword>
	<keyword>Filipinos</keyword>
	<keyword>Amlodipine</keyword>
	<keyword>Olmesartan medoxomil</keyword>
	<keyword>uncontrolled hypertension</keyword>
	<keyword>difficult to treat hypertension</keyword>
</DOC>